Steven Sorscher

1.2k total citations
68 papers, 740 citations indexed

About

Steven Sorscher is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Steven Sorscher has authored 68 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 14 papers in Surgery. Recurrent topics in Steven Sorscher's work include Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (13 papers) and Cancer Genomics and Diagnostics (11 papers). Steven Sorscher is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (13 papers) and Cancer Genomics and Diagnostics (11 papers). Steven Sorscher collaborates with scholars based in United States, United Kingdom and Belgium. Steven Sorscher's co-authors include Andrea Wang‐Gillam, Rama Suresh, Benjamin Tan, Joel Picus, A. Craig Lockhart, James R. Feramisco, Feng Gao, David C. Linehan, Peter S. Goedegebuure and Stacey M. Plambeck-Suess and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Steven Sorscher

63 papers receiving 728 citations

Peers

Steven Sorscher
Steven Sorscher
Citations per year, relative to Steven Sorscher Steven Sorscher (= 1×) peers Mika Mizuno

Countries citing papers authored by Steven Sorscher

Since Specialization
Citations

This map shows the geographic impact of Steven Sorscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Sorscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Sorscher more than expected).

Fields of papers citing papers by Steven Sorscher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Sorscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Sorscher. The network helps show where Steven Sorscher may publish in the future.

Co-authorship network of co-authors of Steven Sorscher

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Sorscher. A scholar is included among the top collaborators of Steven Sorscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Sorscher. Steven Sorscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sorscher, Steven. (2024). A dual biomarker in non-small cell lung cancer that predicts Li Fraumeni syndrome. Familial Cancer. 23(4). 469–471.
2.
Sorscher, Steven. (2024). Personalized oncology, ethics and adherence to NCCN guidelines. Medical Oncology. 41(11). 272–272. 1 indexed citations
3.
Sorscher, Steven. (2023). Precision oncology comes of age. JAAPA. 36(4). 28–31. 1 indexed citations
4.
Sorscher, Steven. (2023). Primary Care Implications of the Expanded National Guidelines for Germline Testing of Patients Previously Diagnosed with Colorectal Cancer. The Journal of the American Board of Family Medicine. 36(2). 360–365. 3 indexed citations
5.
Amin, Manik, Kathryn Trinkaus, Amberly Brown, et al.. (2019). Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer. Journal of Gastrointestinal Oncology. 10(3). 412–420. 7 indexed citations
6.
Sorscher, Steven. (2019). Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression. Breast Cancer Research and Treatment. 178(2). 469–471. 5 indexed citations
7.
Sorscher, Steven & Shakti Ramkissoon. (2017). Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance. Case Reports in Oncology. 10(2). 634–637. 3 indexed citations
8.
Cho, May, Andrea Wang‐Gillam, Robert J. Myerson, et al.. (2015). A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma. HPB. 17(7). 587–593. 12 indexed citations
9.
Sorscher, Steven, et al.. (2013). A molecularly confirmed neuroendocrine tumor resulting from Lynch Syndrome.. PubMed. 4(1). 95–6. 7 indexed citations
10.
Wang‐Gillam, Andrea, Stacey M. Plambeck-Suess, Peter S. Goedegebuure, et al.. (2012). A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma. Investigational New Drugs. 31(3). 707–713. 81 indexed citations
11.
Sorscher, Steven. (2011). Acinar Cell Carcinoma Responding to Carboplatin/Etoposide Chemotherapy. Journal of Gastrointestinal Cancer. 43(S1). 2–3. 2 indexed citations
12.
Sorscher, Steven. (2008). Hepatocellular carcinoma developing years after extended field radiation for Hodgkin's lymphoma. Acta Oncologica. 47(8). 1606–1607. 2 indexed citations
13.
Sorscher, Steven. (2008). Metastatic acinar cell carcinoma of the pancreas responding to gemcitabine, 5-fluorouracil and leucovorin therapy: a case report. European Journal of Cancer Care. 18(3). 318–319. 14 indexed citations
14.
Sorscher, Steven. (2007). Biological therapy update in colorectal cancer. Expert Opinion on Biological Therapy. 7(4). 509–519. 9 indexed citations
15.
Sorscher, Steven. (2004). Penile Involvement with Hand-Foot Syndrome. American Journal of Clinical Dermatology. 5(3). 209–210. 7 indexed citations
16.
Sorscher, Steven. (2004). Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer. Cancer Chemotherapy and Pharmacology. 54(2). 191–2. 21 indexed citations
17.
Mehdi, Syed A., Arthur H. Tatum, Nancy Newman, et al.. (1999). Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up. Clinical Lung Cancer. 1(1). 59–67. 26 indexed citations
18.
Sorscher, Steven, et al.. (1995). Enhanced E-Cadherin Expression in Epidermal Growth Factor Receptor Expressing Cells. Biochemical and Biophysical Research Communications. 206(2). 518–524. 9 indexed citations
19.
Sorscher, Steven, et al.. (1993). Microinjection of an NM23-Specific Antibody Inhibits Cell Division in Rat Embryo Fibroblasts. Biochemical and Biophysical Research Communications. 195(1). 336–345. 18 indexed citations
20.
Sorscher, Steven, Jan Lillienau, Judy L. Meinkoth, et al.. (1992). Conjugated bile acid uptake by Xenopus laevis oocytes induced by microinjection with ileal poly A+ mRNA. Biochemical and Biophysical Research Communications. 186(3). 1455–1462. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026